Logo image of FNA

PARAGON 28 INC (FNA) Stock Fundamental Analysis

NYSE:FNA - US69913P1057 - Common Stock

13.09 USD
0 (0%)
Last: 4/17/2025, 8:20:50 PM
13.11 USD
+0.02 (+0.15%)
After Hours: 4/17/2025, 8:20:50 PM
Fundamental Rating

3

Overall FNA gets a fundamental rating of 3 out of 10. We evaluated FNA against 185 industry peers in the Health Care Equipment & Supplies industry. While FNA seems to be doing ok healthwise, there are quite some concerns on its profitability. FNA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

FNA had negative earnings in the past year.
FNA had a negative operating cash flow in the past year.
FNA had negative earnings in 4 of the past 5 years.
In the past 5 years FNA reported 4 times negative operating cash flow.
FNA Yearly Net Income VS EBIT VS OCF VS FCFFNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

FNA has a Return On Assets of -18.79%. This is comparable to the rest of the industry: FNA outperforms 52.36% of its industry peers.
With a Return On Equity value of -41.84%, FNA perfoms like the industry average, outperforming 53.40% of the companies in the same industry.
Industry RankSector Rank
ROA -18.79%
ROE -41.84%
ROIC N/A
ROA(3y)-19.77%
ROA(5y)-12.48%
ROE(3y)-38.84%
ROE(5y)-23.97%
ROIC(3y)N/A
ROIC(5y)N/A
FNA Yearly ROA, ROE, ROICFNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

The Gross Margin of FNA (74.75%) is better than 86.91% of its industry peers.
FNA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for FNA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.62%
GM growth 5Y-1.89%
FNA Yearly Profit, Operating, Gross MarginsFNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

4

2. Health

2.1 Basic Checks

FNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
FNA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for FNA has been increased compared to 5 years ago.
Compared to 1 year ago, FNA has a worse debt to assets ratio.
FNA Yearly Shares OutstandingFNA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
FNA Yearly Total Debt VS Total AssetsFNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

FNA has an Altman-Z score of 4.18. This indicates that FNA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of FNA (4.18) is better than 76.44% of its industry peers.
A Debt/Equity ratio of 0.84 indicates that FNA is somewhat dependend on debt financing.
FNA has a Debt to Equity ratio of 0.84. This is in the lower half of the industry: FNA underperforms 72.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 4.18
ROIC/WACCN/A
WACC9.36%
FNA Yearly LT Debt VS Equity VS FCFFNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.51 indicates that FNA has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.51, FNA is doing good in the industry, outperforming 60.21% of the companies in the same industry.
A Quick Ratio of 1.64 indicates that FNA should not have too much problems paying its short term obligations.
FNA has a Quick ratio of 1.64. This is comparable to the rest of the industry: FNA outperforms 41.88% of its industry peers.
Industry RankSector Rank
Current Ratio 3.51
Quick Ratio 1.64
FNA Yearly Current Assets VS Current LiabilitesFNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

FNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.53%.
Looking at the last year, FNA shows a quite strong growth in Revenue. The Revenue has grown by 18.39% in the last year.
FNA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.23% yearly.
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
Revenue 1Y (TTM)18.39%
Revenue growth 3Y20.2%
Revenue growth 5Y19.23%
Sales Q2Q%18.47%

3.2 Future

Based on estimates for the next years, FNA will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.91% on average per year.
Based on estimates for the next years, FNA will show a quite strong growth in Revenue. The Revenue will grow by 18.63% on average per year.
EPS Next Y25.22%
EPS Next 2Y21.57%
EPS Next 3Y6.22%
EPS Next 5Y8.91%
Revenue Next Year14.16%
Revenue Next 2Y14.04%
Revenue Next 3Y18.74%
Revenue Next 5Y18.63%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
FNA Yearly Revenue VS EstimatesFNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
FNA Yearly EPS VS EstimatesFNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

FNA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FNA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FNA Price Earnings VS Forward Price EarningsFNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FNA Per share dataFNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.57%
EPS Next 3Y6.22%

0

5. Dividend

5.1 Amount

No dividends for FNA!.
Industry RankSector Rank
Dividend Yield N/A

PARAGON 28 INC

NYSE:FNA (4/17/2025, 8:20:50 PM)

After market: 13.11 +0.02 (+0.15%)

13.09

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)05-08 2025-05-08/amc
Inst Owners56.68%
Inst Owner Change-89.21%
Ins Owners15.11%
Ins Owner Change-15.06%
Market Cap1.10B
Analysts72
Price Target14.28 (9.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.65%
Min EPS beat(2)-6.82%
Max EPS beat(2)5.52%
EPS beat(4)2
Avg EPS beat(4)-11.35%
Min EPS beat(4)-44.11%
Max EPS beat(4)5.52%
EPS beat(8)3
Avg EPS beat(8)-27.56%
EPS beat(12)3
Avg EPS beat(12)-39.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.09%
Min Revenue beat(2)0.3%
Max Revenue beat(2)1.87%
Revenue beat(4)4
Avg Revenue beat(4)1.03%
Min Revenue beat(4)0.3%
Max Revenue beat(4)1.87%
Revenue beat(8)7
Avg Revenue beat(8)0.91%
Revenue beat(12)11
Avg Revenue beat(12)2.45%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.1%
EPS NY rev (1m)0%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.29
P/FCF N/A
P/OCF N/A
P/B 8.41
P/tB 12.96
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS3.05
BVpS1.56
TBVpS1.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.79%
ROE -41.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.75%
FCFM N/A
ROA(3y)-19.77%
ROA(5y)-12.48%
ROE(3y)-38.84%
ROE(5y)-23.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.62%
GM growth 5Y-1.89%
F-Score2
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 91.39%
Cap/Sales 6.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.51
Quick Ratio 1.64
Altman-Z 4.18
F-Score2
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)195.19%
Cap/Depr(5y)198.62%
Cap/Sales(3y)14.44%
Cap/Sales(5y)13.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
EPS Next Y25.22%
EPS Next 2Y21.57%
EPS Next 3Y6.22%
EPS Next 5Y8.91%
Revenue 1Y (TTM)18.39%
Revenue growth 3Y20.2%
Revenue growth 5Y19.23%
Sales Q2Q%18.47%
Revenue Next Year14.16%
Revenue Next 2Y14.04%
Revenue Next 3Y18.74%
Revenue Next 5Y18.63%
EBIT growth 1Y-9.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.67%
EBIT Next 3Y35.33%
EBIT Next 5Y30.86%
FCF growth 1Y52.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.51%
OCF growth 3YN/A
OCF growth 5YN/A